PBYI

News Puma Biotechnology executive sells over $9,600 in stock - Investing.com

14d ago

News Implied Volatility Surging for Puma Biotechnology (PBYI) Stock Options

14d ago

News Puma forecasts $202M-$206M in 2026 NERLYNX net product revenue while planning alisertib dose escalation and new Lung2 trial

25d ago

Scanner Large down move: 25.0% (2.4x normal daily movement)

91d ago

News Puma anticipates $194M–$198M NERLYNX revenue for 2026 while advancing alisertib clinical programs

95d ago

News Puma Biotechnology Non-GAAP EPS of $0.29 beats by $0.06, revenue of $75.5M beats by $6.9M

95d ago

News Anta takes Aim At Global Big Leagues With Puma Bid

139d ago

News Exclusive: China's Anta Sports has offered to buy Pinault family's 29% Puma stake, sources say

145d ago

News Puma gains on report Anta Sports offered to buy Pinault family's 29% stake

145d ago